Europeans: Careful with the Russian vaccine, one paralyzed.

A high official The EMA (European Medicines Agency/European Barments Agency) called on members of the European Union Sunday to refrain from granting national approval to the Russian COVID vaccine-19 “Sputnik V”, due to its security and effectiveness.

A cadet at the Smolensk Military Academy was paralyzed after taking the Russian vaccine against COVID-19, “Sputnik V”

We need documents we can consider. We, too, at the moment have no record... for the vaccinated people. It's unknown. That's why I would urgently advise against granting a national emergency authorization”, said the head of the EMA Steering Board, Christa Withurer-Hoche, for a conversation on the Austrian broadcaster. ORF, Western media broadcast.

We can have Sputnik V in the market here in the future when the right data is reviewed. The rotary revision has now started in EMA”, she added after the agency said last week it had started such a revision.

The data package comes from Russian producers, and of course they will be revised according to European standards of quality, security and efficiency. When all is proven, it will also be authorized in the European Union”, she added.

Sputnik V has already been approved or assessed for approval in three EU member states -- Hungary, Slovakia and the Czech Republic -- and EU officials have said Brussels could start negotiations with a vaccine producer if at least four member states demand it.

Inrtumber-Hoche said the EMA Committee for Medical Products for Human Use will hold an extraordinary meeting on 11 March to examine Johnson & Johnson COVID-19 for use in the EU.

“We expect a positive assessment and that the Commission (European) will soon grant authorisation”, she added.